Teitur Trophics

Teitur Trophics is a danish biotech company, developing novel treatments for neurodegenerative diseases.

General Information
Company Name
Teitur Trophics
Founded Year
2020
Location (Offices)
Denmark +1
Founders / Decision Makers
Number of Employees
20
Industries
Biotechnology, Life Sciences
Funding Stage
Series A
Social Media

Teitur Trophics - Company Profile

Teitur Trophics is a Danish biotech company, with a mission to develop innovative treatments for neurodegenerative diseases. Founded in 2020, the company's name, "Teitur," is derived from Old Norse for happiness, reflecting their commitment to improving the lives of those affected by neurodegenerative conditions. Specializing in the biotechnology sector, Teitur Trophics recently secured a significant €28.00M Series A investment on 14 March 2023. The investors in this round included Industrifonden, Sunstone Capital, Innovestor, Sound Bioventures, and p53.

Taxonomy: biotech, neurodegenerative diseases, treatment development, therapeutics, medical research, drug development

Funding Rounds & Investors of Teitur Trophics (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A €28.00M 5 p53 14 Mar 2023

Latest News of Teitur Trophics

View All

No recent news or press coverage available for Teitur Trophics.

Similar Companies to Teitur Trophics

View All
Neurotrope Inc. - Similar company to Teitur Trophics
Neurotrope Inc. Developing a new approach to combating Alzheimer's disease and other neurodegenerative diseases.
Harness Therapeutics - Similar company to Teitur Trophics
Harness Therapeutics Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
Nevrargenics Ltd. - Similar company to Teitur Trophics
Nevrargenics Ltd. Developing novel medicines for ALS, FTD, Parkinson’s, Alzheimer’s and other neurodegenerative diseases
GeNeuro SA - Similar company to Teitur Trophics
GeNeuro SA We focus on Human Endogenous Retroviruses (#HERVs) to fight neurodegeneration in #MS, #ALS and #LongCovid $GNRO